Blog

Today, former Vermont Governor and Democratic National Committee (DNC) Chair Howard Dean published an opinion piece in the Hartford Courant arguing that in order to maintain American leadership in innovation, the Biden administration must take a stand for IP rights by decisively rejecting the use of the Bayh-Dole Act’s “march-in” provision to control prices. Passed

September was a busy month for C4IP! Here’s a roundup of what our Coalition has accomplished over the past month. On October 3, C4IP Executive Director Frank Cullen issued a statement in support of the recently-reintroduced Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act. “The legislation will take meaningful steps to

C4IP is recognizing patents, copyrights, and trademarks registered during the month of September for historic inventions that changed their industries and the way we live today. 1948: On September 7, Louis Parker received a patent for the television receiver, which allowed sound and picture to be coordinated and continues to be an integral part of all modern televisions. In 2021,

Former Georgia Congressman Doug Collins recently published an opinion piece in the Atlanta Journal-Constitution on how 11 years of ill-informed Supreme Court decisions have substantially weakened IP rights and set back American innovation — and how the Patent Eligibility Restoration Act would remedy this problem to revitalize numerous high-tech industries. Collins explains how rulings like

Walter Copan, Ph.D. — vice president for research and technology transfer at the Colorado School of Mines, senior advisor with the Center for Strategic and International Studies (CSIS), and former director of the National Institute of Standards and Technology (NIST) — recently published an opinion piece in the Boulder Daily Camera explaining the importance of

Claim: During the NIH’s virtual workshop on July 31, Knowledge Ecology International’s (KEI) James Love claimed that the “reasonable pricing” provision required by the NIH in its Cooperative Research and Development Agreements (CRADAs)…

C4IP is recognizing Clarence Birdseye — the “Father of Frozen Food” — whose invention of the quick-freezing method pioneered the modern frozen foods industry. Clarence Birdseye was born in 1886 in Brooklyn, New York. From an early age, Birdseye had a strong interest in the natural sciences; he studied biology for two years at Amherst College before leaving to

Today, former Texas Congressman Lamar Smith published an opinion piece in the Dallas Morning News on two bipartisan bills that could revitalize innovation and help entrepreneurs in the United States: the PREVAIL Act and the Patent Eligibility Restoration Act. The PREVAIL Act would reform the Patent Trial and Appeal Board (PTAB), preventing Big Tech firms

C4IP was productive during the month of August! Here’s a roundup of what our Coalition was up to over the past month. September 28 will mark the one-year anniversary of C4IP’s launch. We look forward to many more years to come, dedicated to promoting strong and effective IP rights. On September 10, C4IP Co-Chair Andrei

C4IP is recognizing patents, copyrights, and trademarks registered during the month of August for historic inventions that changed their industries and the way we live today. 1930: On August 26, Philo T. Farnsworth received a patent for the first completely electronic television, laying the foundation for an industry that would revolutionize news, sports, and entertainment.

Over the weekend, former DNC Chair and Vermont Gov. Howard Dean published an opinion piece in the Boston Herald encouraging Congress to pass the Patent Eligibility Restoration Act. The legislation, introduced by Senators Chris Coons (D-DE) and Thom Tillis (R-NC), aims to eliminate uncertainty caused by Supreme Court rulings around what types of inventions are

On July 31, the National Institutes of Health (NIH) held a workshop with the intent of delving into the policies and methods that guide biomedical innovation and ensure public access to discoveries supported by the agency. The forum aimed to address the NIH’s approach to patenting and licensing biomedical inventions. Additional topics included the agency’s